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Rotavirus-specific cytotoxic T lymphocytes (CTL) play an important role in the resolution of rotavirus infection. The outer
capsid glycoprotein, VP7, elicits a class I MHC-restricted CTL response. Vaccinia virus recombinants expressing the VP7
genes from simian rotavirus SA11 (serotype G3) and from the RF strain of bovine rotavirus (serotype G6) were used to
analyze the CTL activity to this antigen in BALB/c (H-2d) and C57BL/6 (H-2b) mice neonatally infected with homologous and
heterologous rotaviruses. A vaccinia virus recombinant expressing the first amino-terminal 88 amino acids of VP7 was
constructed and used to search for cross-reactive CTL against this region of the protein. By using synthetic Kb, Db, and Kd
motif-fitting peptides two overlapping CTL epitopes have been identified located in the first hydrophobic domain (H1) of VP7.
Splenocytes obtained from rotavirus SA11-infected C57BL/6 mice induced the strongest CTL response against target cells
sensitized with a peptide containing a Kb-restricted CTL epitope (amino acids 8–16). A second Kd-restricted epitope (residues
5–13) was recognized by splenocytes derived from rotavirus-infected BALB/c mice. These findings reveal the existence of
CTL epitopes in the H1 signal sequence of the VP7 glycoprotein that coexist with a CTL epitope (residues 31–40) previously
described within the H2 region. © 1999 Academic Press
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Group A rotaviruses are one of the leading causes of
iral gastroenteritis in infants and young children
Kapikian and Chanock, 1996). Infected subjects may be
rotected against subsequent infection and this protec-
ion reduces the severity of the diarrhea (Coulson et al.,
992; Vela´zquez et al., 1996). Despite extensive research
n rotavirus, the precise nature of the immunological
ffector mechanisms involved in protection against rota-
irus disease are only partly understood (Midthun and
apikian, 1996; Ward, 1996) and such knowledge is
eeded in order to design an efficient vaccine strategy.
n oral rotavirus vaccine was recently approved since
he results obtained in clinical trials proved that it in-
uces a significant reduction in severe diarrhea caused
y rotavirus (Bernstein et al., 1995; Pe´rez-Schael et al.,
997).
Cytotoxic T lymphocytes (CTL) are thought to be im-
ortant in controlling primary rotavirus infections and in
he immune protection against reinfections (Offit and
udzik, 1988; Franco et al., 1997; Heath et al., 1997).
lthough antibodies, mainly rotavirus-specific intestinal
gA, seem to be important determinants of protection
gainst rotavirus reinfection in mice (McNeal et al., 1995;
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424ranco and Greenberg, 1995; Moser et al., 1998) and in
umans (Matson et al., 1993; Ward and Bernstein, 1995;
olomina et al., 1998), a role for CD81 T cells in protec-
ion from viral reinfection has also been recognized (Mc-
eal et al., 1995; Franco et al., 1997). There are data from
xperimental rotavirus infections in mice that support the
ypothesis that rotavirus-specific CTL may protect
gainst disease. Rotavirus-specific CTL are detected at
he intestinal mucosal surface in mice within the first
eek of infection (Offit and Dudzik, 1989). CD81 T cells
rom rotavirus-immunized adult mice passively protect
uckling mice against rotavirus gastroenteritis in the
bsence of rotavirus-specific neutralizing antibodies (Of-
it and Dudzik, 1990) and mediate the clearance of
hronic rotavirus infection in SCID mice (Dharakul et al.,
990). To better characterize the effector mechanisms
nvolved in the clearance and prevention of rotavirus
nfection, Franco and Greenberg (1995) studied rotavirus
nfections in gene knockout transgenic mice devoid of
oth T and B cells (Rag-2 gene knockout mice), CTL
b2-microglobulin knockout mice), and B cells (JHD
nockout mice). Animals depleted of CD81 T cells have
delay in clearance of rotavirus infection and, in the
bsence of B cells, they become chronically infected
ith murine rotavirus. It has also been reported that
D81 cells are involved in the resolution of the initial
nfection in two B-cell-deficient mouse strains (JHD and
MT mice) inoculated with the murine rotavirus strain
DIM (McNeal et al., 1995). Furthermore, it has been
hown experimentally that CD81 T cells can mediate
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425CTL EPITOPES IN ROTAVIRUS VP7lmost complete short-term and partial long-term protec-
ion from reinfection in mice (Franco et al., 1997).
Several studies have demonstrated that the rotaviral
P7 glycoprotein induces a vigorous specific CTL re-
ponse (Offit et al., 1991a, 1994; Heath et al., 1997). By
noculating mice orally with recombinant vaccinia vi-
uses (rVV) expressing individual rotavirus genes, Offit et
l. (1994) found that the greatest frequencies of virus-
pecific CTL were induced by recombinants expressing
P7. These rotavirus-specific CTL recognized different
irus VP7 (G) serotypes and were induced in both intes-
inal and nonintestinal lymphocytes after oral inoculation.
imilar results were obtained by Heath et al. (1997), who
sed vaccinia virus recombinants expressing VP7 genes
rom seven G serotypes in cytotoxicity assays and found
hat the CTL response to VP7 is completely cross-reac-
ive.
To gain a better understanding of the CTL response
gainst the rotaviral VP7 glycoprotein we have carried
ut cytotoxicity assays using vaccinia virus recombi-
ants expressing the VP7 molecule from both the SA11
train of simian rotavirus (serotype G3) (VV-VP7-SA11)
nd the RF strain of bovine rotavirus (serotype G6) (VV-
P7-RF) and a vaccinia virus expressing a carboxy-ter-
inally truncated VP7 protein comprising the first 88
mino acids of the SA11 protein (VV-VP7-59). Synthetic
eptides encompassing Kb, Db, and Kd allele-specific
otifs were then used in CTL assays in order to deter-
ine the VP7 epitopes recognized by CTL.
RESULTS
xpression of rotavirus VP7 by recombinant vaccinia
iruses
Recombinant vaccinia viruses were produced to ex-
ress (i) full-length VP7 from rotavirus strain SA11 (VV-
P7-SA11), (ii) a carboxy-terminally truncated molecule
omprising the first 88 amino acids of the SA11 VP7
rotein (VV-VP7-59), and (iii) b-galactosidase encoded by
he Escherichia coli lacZ gene from the transfer plasmid
SC11 (VV-sc11). These recombinant viruses were ana-
yzed by polymerase chain reaction (PCR), Southern blot
ybridization, and sequence analysis and the inserts
ere found to be in the correct orientation. VP7 expres-
ion by recombinant vaccinia viruses was assessed by
ndirect immunofluorescence, Western blotting, and ra-
ioimmunoprecipitation assay (RIPA). Recombinant vac-
inia virus-infected CV-1 cells were identified after stain-
ng with a hyperimmune bovine anti-rotavirus serum or
ith monoclonal antibodies against VP7. The reaction
as localized as fluorescent patches in the perinuclear
egion (Fig. 1B), which could correspond to the ER local-
zation of VP7. It is well known that VP7 behaves as an
ntegral membrane protein and that it is acquired by the
irus during the budding process through the ER.The expression of VP7 by both VV-VP7-SA11 and VV- aP7-RF was demonstrated by Western blot analysis us-
ng a hyperimmune goat anti-rotavirus serum (Fig. 2A).
s no positive reaction was observed by immunofluores-
nce or immunoblotting of cells infected with VV-VP7-59,
either with polyclonal antisera nor with monoclonal
ntibodies to VP7, immunoprecipitation of labeled pro-
eins was used as the detection method (Fig. 2B). The
esults obtained by RIP assay using human polyclonal
nti-rotavirus and mouse monoclonal antibodies to VP7
howed that both vaccinia virus recombinants VV-VP7-
A11 and VV-VP7-RF were expressing full-length VP7,
hereas a polypeptide of approximately 9 kDa was pre-
ipitated from cells infected with VV-VP7-59. This mole-
ule corresponded to the truncated VP7 protein encoded
y the 59 fragment of gene 9 cloned into the vaccinia
irus.
The expression of VP7 by VV-VP7-RF and VV-VP7-SA11
as also analyzed by immunofluorescence in those cells
o be used as targets in CTL assays, namely MC57, Balb
l.7, and P815 infected with the rVV. Immunostaining with
Abs against VP7 was found to be of similar intensity
ith both viruses (results not shown).
hallenge of BALB/c and C57BL/6 newborn mice
ith homologous and heterologous rotaviruses
Different percentages of suckling mice inoculated
rally with SA11, EDIM, or Wa rotavirus strains suffered
iarrhea for 2–5 days postinoculation at the doses given.
aking both BALB/c and C57BL/6 mouse strains to-
ether, 88% of mice challenged with SA11, 80% of mice
noculated with EDIM, and 30% of those mice infected
ith Wa developed transient diarrheal disease. Sera
amples obtained from those animals that developed
iarrhea were tested by ELISA for anti-rotavirus antibod-
es and in all the sera examined titers of rotavirus-
pecific IgG higher than 1/500 were found, demonstrat-
ng that the animals had been immunized to the viral
ntigens (results not shown). Splenocytes to be used in
TL assays against rotaviral antigens were obtained
rom those animals that developed disease after viral
noculation and were found to be rotavirus-specific IgG
ositive.
TL responses in mice immunized with SA11 and Wa
otavirus strains
Splenocytes obtained from BALB/c (H-2d) and C57BL/6
H-2b) mice immunized with SA11 rotavirus and restimu-
ated in vitro lysed syngeneic target cells infected not
nly by SA11 rotavirus but also those infected by VV-VP7-
A11 and VV-VP7-RF (Figs. 3A and 3B). These effector
ells therefore recognized in a cross-reactive manner the
P7 from both SA11 (serotype G3) and RF (serotype G6)
otavirus strains. Splenocytes derived from Wa-infected
-2d and H-2b mouse strains clearly elicited a cytolytic
ctivity against target cells infected with SA11 rotavirus
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426 BUESA ET AL.nd with the vaccinia virus recombinant VV-VP7-RF (Figs.
C and 3D). Target cells infected by VV-VP7-59 carrying
he amino terminus of VP7 (amino acids 1–88) were
ecognized and lysed by splenocytes derived from mice
hallenged with both the SA11 and the Wa strains of
otavirus. However, effector cells from Wa-infected
ALB/c H-2d mice manifested a significantly (P , 0.001)
ower response to target cells infected with rVV express-
ng VP7 and with V V-VP7-59 than effector cells from
A11-infected C57BL/6 H-2b mice (Figs. 3B and 3C).
ontrol target cells infected with VV-sc11 or mock-in-
ected were not lysed by the effector cell populations to
significant extent. This trend was observed in both
aplotypes of mice. The MHC restriction in the CTL
ecognition of SA11-infected target cells was confirmed
y the absence of lysis of MC57 cells (H-2b) by effector
ells derived from BALB/c H-2d mice (results not shown).
TL responses in mice immunized with EDIM
otavirus
Effector cells derived from both BALB/c and C57BL/6
FIG. 1. Expression of rotavirus VP7 by recombinant vaccinia viruses
nfected with SA11 rotavirus (A and C) and CV-1 cells were infected wi
ontrol (D). After staining with either a bovine anti-rotavirus polyclona
ppropriate fluorescein-conjugated anti-IgG sera, cells were examinedice challenged with the homologous EDIM strain elic- Tted significant specific lysis of appropriate target cells
nfected with SA11 rotavirus, with recombinant vaccinia
iruses carrying full-length VP7 (VV-VP7-SA11 and VV-
P7-RF), and with rVV expressing the amino terminus of
he protein (VV-VP7-59) (Fig. 4). No significant differences
P 5 0.05) were detected in the lysis values elicited by
TL induced in both strains of mice infected and primed
ith homologous (EDIM) or heterologous (SA11 and Wa)
otaviruses against target cells infected with rotavirus
A11. However, effector cells derived from EDIM-infected
-2d mice elicited a significantly lower CTL response
gainst SA11-infected target cells than effector cells from
-2b mice (P , 0.001).
TL responses to target cells sensitized with
eptides
To identify new CTL epitopes, synthetic peptides were
esigned according to the motifs described by Falk et al.
1991) fitting Kb, Db, and Kd class I alleles. Four possible
b-restricted motifs, one Db-restricted determinant, and
ne potential Kd-restricted epitope were explored (Table 1).
ted and localized by indirect immunofluorescence. MA104 cells were
mbinant vaccinia viruses V V-VP7-SA11 (B) and V V-sc11 as a negative
(C) or an anti-VP7 MAb (A, B and D) and counterstaining with the
hotographed under UV illumination at a magnification of 250X.detec
th reco
l serumable 2 shows the results of the CTL assays performed
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427CTL EPITOPES IN ROTAVIRUS VP7ith splenocytes from mice infected with different rota-
irus strains and stimulated in vitro with peptides against
arget cells sensitized with the appropriate peptide at
026 M. Peptide Kb8–16 (amino acids 8–16) elicited the
trongest specific lysis of MC57 cells mediated by effec-
ors derived from C57BL/6 mice immunized with SA11.
he lysis of MHC-matched target cells sensitized with
eptides Kd5–13 (amino acids 5–13) and Kb31–40 (amino
cids 31–40) at 1026 M was also observed and showed
ysis values at least two times higher than the lysis
alues of control target cells (mock-infected and/or VV-
c11-infected cells) (Table 2). Peptide Kb2-10 was not
ecognized by effector cells derived from C57BL/6 mice
nfected with either SA11 or Wa rotavirus strains, nor was
eptide Db48-57, which encompasses a potential CTL
pitope in the context of H-2Db, recognized. Peptides
ere found to be nontoxic to target cells since the 51Cr
pontaneous release of cells incubated with each pep-
ide was not greater than the spontaneous release with-
ut peptides.
CTL responses to target cells sensitized with peptides
b8–16, Kb31–40, and Kd5–13 at different peptide con-
entrations, ranging from 1025 to 10212 M, confirmed the
FIG. 2. Detection of rotavirus VP7 expressed by vaccinia virus recomb
nalysis, 143TK2 cells were infected with vaccinia virus recombinants a
ostinfection proteins were extracted, subjected to electrophoresis on
as blocked with Tris-buffered saline containing 3% BSA, a hyperimmu
ntibody was an anti-goat IgG peroxidase conjugate and the subs
xpressed by the recombinant vaccinia viruses V V-VP7-RF and V V-V
V-VP7-59, 143TK2 cells were infected with 20 m.o.i. of rV V and prote
ashed and lysed. The radiolabeled lysate from SA11-infected cells w
rom rV V-infected cells were incubated with an anti-VP7 MAb. Immun
lectrophoresis on a 10–20% gradient SDS–polyacrylamide gel. The ge
l., 1998).bility of CTL to detect the epitope defined by each 1eptide and to generate an efficient cell lysis (Figs. 5
nd 6).
To confirm these results, splenocytes derived from
57BL/6 or BALB/c mice primed in vivo with either SA11
r EDIM virus were restimulated in vitro with the same
nfecting viral strain. The cytotoxic capacity of these cells
as then assayed against syngeneic target cells labeled
ith 51Cr and sensitized with peptides Kb8–16, Kb31–40,
r Kd5–13. The results are shown in Table 3 and corrob-
rate the identification of these epitopes by splenocytes
rom mice primed with two different rotavirus strains.
nly peptide Kb8–16 was not recognized by effector cells
rom EDIM-infected C57BL/6 mice.
DISCUSSION
The effector functions responsible for clearance of
otavirus from the intestinal mucosa have been partially
haracterized (McNeal et al., 1995; Offit, 1996). T cells are
urning out to have an important role as frontline senti-
els in the intestinal mucosa against viral infections. The
recise function of the CTL response in rotavirus immu-
ity has been the focus of numerous studies (Offit et al.,
sing Western blotting (A) and immunoprecipitation (B). For immunoblot
104 cells were infected with SA11 rotavirus as a control. At 9 and 24 h
DS–PAGE, and electroblotted onto nitrocellulose. After the membrane
anti-rotavirus serum was added and incubated overnight. The second
sed was 3-amino-9-ethylcarbazole. For immunoprecipitation of VP7
1 and of a carboxy-terminally truncated VP7 molecule expressed by
eled with [35S]methionine:cysteine. At 12 h postinfection, cells were
bated with a polyclonal human anti-rotavirus serum, whereas lysates
plexes were precipitated with protein A–Sepharose and analyzed by
xed, dried, and processed for fluorography as described (Colomina etinants u
nd MA
10% S
ne goat
trate u
P7-SA1
ins lab
as incu
e com
l was fi991b; Franco and Greenberg, 1995; Heath et al., 1997).
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428 BUESA ET AL.otavirus-specific CTL are detected in mucosal nodes
Peyer’s patches and mesenteric lymph nodes) early in
nfection and are later detected in the spleens of rotavi-
us-infected mice (Offit et al., 1991b). It has been dem-
nstrated that CD81 T cells play an important role in the
esolution of rotavirus primary infection and a much
esser role in protection from reinfection (Rose´ et al.,
998; Franco and Greenberg, 1995; Franco et al., 1997).
he in vivo depletion of T cell subpopulations (CD41,
D81, BoWC11) in calves by administration of monoclo-
al antibodies demonstrated that CD81 cells are in-
olved in restricting rotavirus growth and that CD41 T
ymphocytes help the generation of mucosal and sys-
emic rotavirus-specific antibodies (Oldham et al., 1993).
urthermore, it was demonstrated recently that the ex-
ression of the mucosal homing receptor a4b7 correlates
ith the ability of CD81 memory T cells to clear rotavirus
nfections (Rose´ et al., 1998).
In the present study, CTL were generated by inoculat-
ng suckling mice by the oral route to reproduce the
isease in the experimental model such that viral anti-
FIG. 3. Specific lysis of target cells infected with SA11 rotavirus
V V-VP7-SA11 and V V-VP7-RF) or a carboxy-truncated VP7 molecule (V
ice inoculated with SA11 (A, B) or Wa (C, D) rotavirus strains. The effe
ells (for BALB/c, H-2d effectors) and MC57 target cells (for C57BL/6,
accinia virus carrying the lacZ gene (V V-sc11) and mock-infected celens would be primarily processed and presented to T tymphocytes in the gut epithelium, as occurs during the
ourse of natural rotavirus infections. It has been re-
orted that rotavirus-specific CTL activity can be de-
ected as early as 6 days after oral or parenteral inocu-
ation of mice with rotavirus (Offit and Dudzik, 1989).
reliminary experiments in our study showed that the
evels of the CTL response were enhanced when mice
nfected neonatally with rotavirus were primed intraperi-
oneally with 107 PFU of the same virus strain 5 to 7 days
efore their spleens were removed (results not shown).
he first goal of the present study was to determine
hether splenocytes, derived from mice orally infected
ith different strains of rotavirus, mount a CTL response
gainst target cells expressing VP7 from two different
irus strains, the bovine RF strain (serotype G6) and the
imian rotavirus SA11 (serotype G3). Our data confirm
he existence of a cross-reactive CTL activity against VP7
f G3 and G6 specificities by effector cells generated
ith rotavirus strains Wa (G1), SA11 (G3), and EDIM (G3).
his CTL response against VP7 has been found in sev-
ral previous studies to be cross-reactive with respect to
with vaccinia virus recombinants expressing either full-length VP7
9) by splenocytes derived from BALB/c (A, C) and from C57BL/6 (B, D)
ere used in standard (5 h) 51Cr release assays against Balb Cl.7 target
ffectors) as described under Materials and Methods. A recombinant
used as negative controls.and
V-VP7-5
ctors w
H-2b ehe virus G serotype (Offit et al., 1991a; Franco et al.,
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429CTL EPITOPES IN ROTAVIRUS VP7993; Heath et al., 1997) but the cross-reactive T cell
pitope (or epitopes) has not been characterized.
Lysis values of target cells infected with SA11 rotavi-
us were significantly greater (P , 0.001) than those
etected against target cells infected with rVV express-
ng full-length VP7 (V V-VP7-SA11 and VV-VP7-RF). This
bservation could arise for several reasons: (i) a higher
evel of protein expression and presentation of the anti-
enic peptides in rotavirus-infected target cells com-
FIG. 4. Lytic activities of CTL derived from BALB/c H-2d (A) and C57
ells infected with SA11 rotavirus and with vaccinia virus recombinants
ncompassing the first 88 amino acids of the amino-terminal region (V
TABLE 1
CTL Epitopes Investigated with Synthetic Peptides Derived
from the Amino-Terminal Region of VP7
Synthetic peptides
Mouse straineptide/residues Sequencea Motifs
Kb2–10 YGIEYTTVL Kb C57BL/6
Kb8–16 TVLTFLISI Kb C57BL/6
Kd5–13 EYTTVLTFL Kd BALB/c
Kb31–40 DFIIYRFLFI 2 Kb C57BL/6
Db48–57 LRAQNYGINL Db C57BL/6
a The potential MHC main anchor residues are written in boldface in
nach peptide sequence.ared to the rVV-VP7-infected cells; (ii) the generation of
TL responses to viral proteins other than VP7 since
ther target antigens of the rotavirus-specific cytotoxic T
ell response have been identified in the inner capsid
rotein VP6 (Franco et al., 1994), the core protein VP3
Franco et al., 1994), and the nonstructural protein NSP-1
Heath et al., 1997); and (iii) differences in the induction of
TL, the activation of CTLp cells, and the CTL repertoire.
CTL responses manifested by H-2d splenocytes against
arget cells infected with VV-VP7-59 were similar to those
gainst targets infected with VV-VP7-SA11 or VV-VP7-RF. By
ontrast, lysis values of target cells infected with VV-VP7-59
y splenocytes derived from rotavirus-infected H-2b mice
ere significantly lower (P , 0.001) than those detected
gainst target cells infected with rVV expressing full-length
P7. This could be a consequence of the existence of
dditional CTL epitopes in other regions of the VP7 protein
n the H-2b background not expressed by the recombinant
accinia virus VV-VP7-59.
It has been suggested that signal peptides or frag-
ents thereof may be presented by class I MHC an-
igens as T cell epitopes (Henderson et al., 1992). A
ominant target peptide presented by Db and recog-
-2b (B) mice challenged with EDIM rotavirus against syngeneic target
sing either full-length VP7 (V V-VP7-SA11) or a truncated VP7 molecule
-59).BL/6 H
expres
V-VP7ized by cytotoxic T cells specific for lymphocytic
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430 BUESA ET AL.horiomeningitis virus (LCMV) in H-2b mice is derived
rom the signal sequence of the viral glycoprotein
recursor GP-C (Buchmeier and Zinkernagel, 1992).
T
Cytotoxic Activities (% Specific Cell Lysis) of Splenocytes Obtained
Heterologous (SA11 and Wa) Rotavirus Strains D
Infecting
virus strain
Effector cellsa from C57B
Kb31–40/MC57 Kb2–10/MC57 Kb8
SA11 42.1 6 8.3 9.1 6 1.2 53
Wa 30.6 6 3.4 5.5 6 2.4 43
EDIM 28.1 6 7.7 ND 12
a Spleen cells derived from mice infected with different rotavirus stra
t 1024 M for 5 days.
b Target cells were labeled with 51Cr and sensitized with peptides at a
t an E:T ratio of 50:1. The cell mixtures were incubated for 5 h and 51Cr
1Cr release was calculated as described under Materials and Methods
alues at least twice the value of mock-infected or V V-sc11-infected ta
c ND, not determined.
FIG. 5. Specific lysis of target cells sensitized with peptides Kb8–16 an
A11, Wa, or EDIM rotavirus strains. MC57 target cells were incubated for 2atio of 50:1. P815 cells were used as targets to verify the MHC restriction of theoreover, the immunogenicity of an immunorecessive
TL epitope present in the large T antigen of polyoma-
irus simian virus 40 (SV40) was significantly en-
57BL/6 and BALB/c Mice Infected with Homologous (EDIM) and
d against Target Cells Sensitized with Peptides
pecific cell lysis
ce Effector cellsa from BALB/c mice
tideb/target cells
57 Db48–57/MC57 Kd5–13/Balb Cl.7
.2 4.2 6 1.8 32.9 6 3.4
.7 6.3 6 1.5 NDc
.5 8.7 6 2.6 26.5 6 4.6
11, Wa, or EDIM) and stimulated in vitro with the appropriate peptide
ntration of 1026 M for 2 h at 37°C, after which effector cells were added
d in the fluid phase was measured with a gamma counter. The specific
ers shown represent mean values plus and minus the SEM. Cell lysis
lls are shown in boldface type.
40 by peptide-stimulated effector cells from C57BL/6 mice infected with
different peptide concentrations before addition of effectors at an E:T cellABLE 2
from C
irecte
% S
L/6 mi
Pep
–16/MC
.7 6 9
.2 6 8
.8 6 3
ins (SA
conce
release
. Numb
rget ced Kb31–
h witheffector population derived from SA11-infected C57BL/6 mice.
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431CTL EPITOPES IN ROTAVIRUS VP7anced by targeting it to the endoplasmic reticulum
ER) (Fu et al., 1998).
During the rotavirus assembly process, the outer cap-
FIG. 6. Specific lysis of Kd5–13 peptide-sensitized target cells by
eptide-stimulated splenocytes from BALB/c mice infected with either
A11 or EDIM rotavirus strains. P815 target cells were incubated for 2 h
ith different peptide concentrations before addition of effectors at an
:T cell ratio of 50:1. MC57 cells were used as targets to verify the MHC
estriction of the effector population derived from SA11-infected BALB/c
ice.
T
Cytotoxic Activities (% Specific Cell Lysis) of Splenocytes Obtain
nd the Heterologous SA11 Rotavirus Strains, Restimulated in Vitro
ith Peptides
Viral strain used to
prime in vivo and
boost in vitro
Effector cellsa from C57B
1° 2° Kb31–40/MC57 Kb8–16/MC5
A11 SA11 48.6 6 7.3 52.6 6 8.0
DIM EDIM 34.9 6 6.8 8.4 6 2.3
a Spleen cells derived from mice infected with either SA11 or EDIM ro
f the appropriate viral strain and incubated further for 5 days as desc
b Target cells were labeled with 51Cr and sensitized with peptides at a
t an E:T ratio of 50:1. The cell mixtures were incubated for 5 h and 51Cr
1Cr release was calculated as described under Materials and Methods
alues at least twice the value of mock-infected or V V-sc11-infected tac ND, not determined.id VP7 glycoprotein becomes an integral membrane
olypeptide of luminal orientation that probably contrib-
tes to the ability of this particular viral protein to elicit a
TL response. In fact, VP7 is an ER membrane-associ-
ted glycoprotein. The VP7 gene encodes 326 amino
cids that have two tandem hydrophobic domains at the
mino terminus, each preceded by an ATG codon
Poruchynsky et al., 1985). Both hydrophobic sequences,
1 (residues 1–29) and H2 (residues 30–50), can function
s signal peptides to direct the protein into the ER. The
R retention motif of VP7, which does not include KDEL
r lysine residues, has been analyzed in many studies
Poruchynsky et al., 1985; Stirzaker et al., 1987, 1990;
larke et al., 1995). It has been demonstrated that 3
mino acids at the amino terminus, residues lle-9, Thr-
0, and Gly-11, are essential amino acids of the VP7 ER
etention signal (Maass and Atkinson, 1994). Rotavirus is
ne of the few viruses that uses the ER for assembly and
as therefore been an attractive model with which to
tudy ER translocation, retention, and protein folding.
Of the peptides used in the present study to charac-
erize CTL epitopes, three were clearly recognized by
plenocytes from rotavirus-infected mice: Kb8–16 and
b31–40, both presented in the context of H-2Kb, and
d5–13, which is H-2Kd restricted. The sequence of pep-
ide Kb31–40, which contains two potential Kb-restricted
otifs, was previously analyzed by Franco et al. (1993) in
ice immunized with the RF strain of bovine rotavirus.
hey reported that the epitope located at the carboxy-
erminal motif of this peptide is an immunodominant
ytotoxic T cell epitope of the VP7 rotavirus protein. The
nchor positions for both potential epitopes are con-
erved among the amino acid sequences of rotavirus
trains SA11, RF, Wa, and EDIM, as well as in the other
C57BL/6 and BALB/c Mice Infected with the Homologous EDIM
e Same Viral Strains and Directed against Target Cells Sensitized
% Specific cell lysis
ce Effector cellsa from BALB/c mice
Peptideb/target cells
None/MC57 Kd5–13/Balb Cl.7 None/Balb Cl.7
6.7 6 4.3 26.0 6 5.2 4.6 6 3.1
5.2 6 3.5 22.8 6 6.9 NDc
strains were mixed in vitro with stimulator cells incubated with 1 m.o.i.
nder Materials and Methods.
ntration of 1026 M for 2 h at 37°C, after which effector cells were added
ed in the fluid phase was measured in a gamma counter. The specific
ers shown represent mean values plus and minus the SEM. Cell lysis
lls are shown in boldface type.ABLE 3
ed from
with th
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432 BUESA ET AL.otavirus strains compared in Table 4, making this
pitope a good candidate for the cross-reactivity to VP7.
t is interesting to note that the sequence of peptide
b48–57 (which encompasses a potential H-2Db-re-
tricted epitope) is highly conserved in all the rotavirus
trains analyzed, except for the first two amino acids.
owever, this peptide was not recognized in CTL assays.
s was established by Oldstone et al. (1995), the predic-
ion of potential CTL epitopes based merely on primary
equence analysis and identification of MHC class I
llele specific anchoring motifs is of limited value, and
nly a restricted number induce CTL activity.
CTL responses generated by splenocytes from SA11
nd Wa-infected mice to target cells sensitized with pep-
ide Kb8–16 (TVLTFLISI) were stronger than those de-
ected against target cells sensitized with peptide Kb31–
0. This intense CTL activity, with recognition and lysis of
ells expressing peptide Kb8–16, was not detected with
ffector cells derived from EDIM-infected H-2b mice. This
an be explained by the differences occurring in the last
nchor residue of the H-2Kb-restricted motif, I-16 for F in
he VP7 sequence of the EDIM strain, which occurs in
ouse rotavirus strains (EW, EB) and in some human
trains such as HCR3 and PV5249 (Table 4). It is well
nown that single amino acid substitutions within a class
Note. The sequences of the amino-terminal regions of 12 strains of an
s that originally reported by Both et al. (1983) (GenBank Accession No
-37 to F, which were confirmed by the sequencing of the SA11 strain
ectangles A, B, and C, respectively. Amino acid residues that are iden-restricted epitope can abrogate CTL recognition by dliminating the proteolytic cleavage site required for the
eneration of the antigenic peptide, by decreasing the
inding affinity of the peptide for the MHC molecule, or
y altering the peptide–MHC complex so that it is no
onger recognized by the T cell receptor (Couillin et al.,
994; Ossendorp et al., 1996). In addition, peptide Kd5–13
EYTTVLTFL) was found to generate recognition and
ysis by CTL from both SA11 and EDIM-infected BALB/c
-2d mice. As observed in the screening experiments
Table 2), the peptide dilution experiment (Fig. 6) con-
irmed the specific cytotoxicity against peptide Kd5–13-
ensitized target cells. From our results, we conclude
hat both epitopes, whose sequences overlap and which
re located within the H1 signal sequence of the VP7
lycoprotein, are recognized by splenocytes derived
rom rotavirus-infected mice. However, experiments de-
igned to provide evidence that the synthetic peptides
sed in our study represent the optimal ones for each
TL response remain to be performed.
It has been shown that there is a hierarchy in the
pitope specificity of MHC class I-restricted epitopes
van der Most et al., 1996). CTL determinants can be
ominant, subdominant, or even cryptic. It has been
ostulated that in vivo activation of subdominant
pitopes can occur in some viral infections, that CTL
d human rotaviruses are shown for comparison. The sequence of SA11
6) with two changes reported by Stirzaker et al. (1987), C-32 to F and
in this study. Peptides Kd5–13, Kb8–16, and Kb31–40 are enclosed in
that of SA11 are shown as dashes (–).imal an
. V0154
usedirected against these epitopes are capable of control-
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433CTL EPITOPES IN ROTAVIRUS VP7ing infection, and that previously subdominant epitopes
an become dominant under different conditions
Lewicki et al., 1995; van der Most et al., 1996). The
ierarchy among the CTL epitopes identified so far in
P7 needs to be determined.
The observation that CTL epitopes form clusters within
iral proteins has recently been described in viruses
nfecting both humans and mice. The existence of over-
apping epitopes has been reported in the influenza A
irus nucleoprotein (Tussey et al., 1995) as well as in the
uman immunodeficiency virus type 1 gp120 presented
y HLA A, B, and C molecules (Wilson et al., 1997).
ikewise, it has been found in H-2b mice that the H-2b-
estricted epitope contained in the signal sequence of
ymphocytic choriomeningitis virus GP1 also harbors an
-2Db-restricted binding motif (Hudrisier et al., 1997).
Comparative analysis of the VP7 amino acid se-
uences of strains belonging to the G3 serotype has
evealed similarities ranging from 88.7 to 99.4%, whereas
mong strains representing 13 G serotypes amino acid
equence similarities range from 60.4 to 88.3% (Li et al.,
994). Although sequence divergence has been found to
ccur primarily in the VP7-serotype-specific regions, the
mino-terminal region of VP7 is not as well conserved as
he carboxy-terminal sequence (Kapikian and Chanock,
996). This favors the hypothesis that CTL epitopes can
e variable among different strains and serotypes of
otavirus. However, it is interesting to know which
pitopes mount CTL responses sufficient to clear virus
nd control infection. Such information will open the way
o the development of DNA vaccines that might deliver
ultiple CTL epitopes to generate DC81 CTL responses
Chen et al., 1998).
MATERIALS AND METHODS
ice
Four- to six-week-old BALB/c (H-2d) and C57BL/6 (H-
b) mice were purchased from IFFA Credo (Barcelona,
pain). The animals were periodically tested for the ab-
ence of anti-rotavirus antibody by ELISA. Uninfected
ice remained seronegative during the study. They were
eared separately from the rotavirus-infected animals,
hich were kept in different animal facilities. All proce-
ures were conducted in accordance with the regula-
ions established by the European Community Council
n the protection of animals with experimental and sci-
ntific applications (86/609/CEE).
ell lines
MA104 cells were grown in Eagle’s minimum essential
edium supplemented with 10% heat-inactivated fetal
ovine serum (FBS) (Gibco BRL, Paisley, UK), 2 mM
-glutamine, 100 mg/ml streptomycin sulfate, and 100
nits/ml penicillin. CV-1 cells were grown in Dulbecco’s codified Eagle’s medium (Gibco BRL) containing 10%
BS. Plastic-adherent 143TK2 (H-2b), MC57 (H-2b), and
alb Cl.7 (H-2d) cells were generously provided by J. L.
hitton (The Scripps Research Institute, La Jolla, CA)
nd grown as described (Whitton et al., 1988a). P815
H-2d) cells, obtained from M. del Val (Institute of Health
arlos III, Madrid, Spain), were grown in RPMI 1640
edium (Gibco BRL) supplemented with 10% FBS.
irus strains
Simian rotavirus SA11 (serotype G3, P[2]) [American
ype Culture Collection (ATCC) VR-899), Rockville, MD],
uman rotavirus Wa (serotype G1, P1A[8]) (ATCC VR-968),
nd murine rotavirus EDIM (G3, P10 [16]), originally ob-
ained from R. Ward (Children’s Hospital Research Foun-
ation, Cinncinati, OH), were grown in MA104 cells in the
resence of 1 mg/ml trypsin (type IX, Sigma Chemical
o., St. Louis, MO) as previously described (Sato et al.,
981). The titers of the SA11 and Wa viral stocks were
etermined by plaque assay as described (Urasawa et
l., 1982) and EDIM virus preparations were quantified by
fluorescence focus assay described elsewhere (Bern-
tein et al., 1987).
Vaccinia virus (WR strain) (American Type Culture Col-
ection) was used to generate recombinant viruses. A
accinia virus recombinant with gene 9 of bovine rotavi-
us strain RF (serotype G6) was kindly provided by J.
ohen (INRA, Jouy-en-Josas, France). Vaccinia viruses
ere propagated on CV-1 cells as described (Chakra-
arti et al., 1985).
urification of viral RNA and synthesis of cDNA
MA104 cells were infected with 1 m.o.i. of the SA11
otavirus previously activated with 10 mg/ml of trypsin.
hen a 90% cytopathic effect was achieved, cell cultures
ere freeze-thawed three times and fluorocarbon ex-
racted as described (Offit et al., 1983). Viral RNA was
btained from the crude virus preparation by phenol–
hloroform extraction and ethanol precipitation. Reverse
ranscription–polymerase chain reaction (RT–PCR) was
pplied to generate and amplify cDNA of rotavirus gene
as previously described (Buesa et al., 1996). The prim-
rs used have been described by Gouvea et al. (1990)
nd are specific for the gene coding for VP7, which may
e RNA segment 7, 8, or 9 depending on the viral strain,
nd produce full-length copies of the gene from any
roup A rotavirus strain.
loning of the VP7 gene in pSC11 vector
Following standard cloning procedures (Ausubel et al.,
996) the VP7 cDNA of SA11 rotavirus was cloned into
he SmaI site of the transfer plasmid pSC11 (Chakrabarti
t al., 1985). Ligation products were transformed into E.
oli strain DH5a and colonies containing recombinant
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434 BUESA ET AL.lasmids were selected by PCR using primers described
y Sheng et al. (1993).
onstruction of a gene 9 59 fragment that codes for a
arboxy-terminally truncated VP7 protein
The following 59 and 39 primers were designed to
mplify a cDNA fragment from SA11 rotavirus gene 9
ncoding amino acids 1 to 88 of VP7, with the inclusion
f the restriction sites EcoRI and BamHI, respectively, in
rder to allow the cloning of this fragment in the pUTT2
ector: 59-GGC TTT AAA AGA GAG AAT TCC CGT TTG G
nucleotides 1–28, EcoRI sequence underlined) and 59-
TC AGT CGG ATC CTC AGT CGG AT (complementary to
ucleotides 302–324, BamHI sequence underlined). The
UTT2 plasmid encodes a translational termination
odon in each of the three reading frames downstream
f a multiple cloning site (Whitton et al., 1988b). The 59
ragment of rotavirus gene 9 was excised from pUTT2 by
coRI and HindIII digestion, termini were made blunt
ith Klenow enzyme, and the fragment was cloned into
he SmaI site of the pSC11 vector. The nucleotide se-
uence of the insert was determined using the T7 RNA
equence System (Amersham Pharmacia Biotech, Rain-
am, UK).
onstruction of recombinant vaccinia viruses
Recombinant vaccinia viruses were produced essen-
ially as described by Earl and Moss (1993). Briefly, CV-1
ells infected with vaccinia virus were transfected with
00 ng of calcium phosphate-precipitated recombinant
lasmid pSC11-VP7. Thymidine kinase selection and
creening of recombinant virus plaques were carried out
n 143TK2 cells grown in minimum essential medium
ontaining 2.5% FBS and 25 mg/ml 5-bromodeoxyuridine.
or plaque assays involving the isolation of recombinant
iruses, 200 mg/ml of XGal (Promega, Madison, WI) was
dded in the agarose overlay. For use as negative con-
rol, a vaccinia virus recombinant carrying the lacZ gene
rom the transfer plasmid pSC11 (VV-sc11) was con-
tructed. Three cycles of plaque purification were carried
ut before recombinant plaque isolates were amplified
or use in CTL assays.
nalysis of recombinant viruses by PCR, Southern
lot hybridization, and nucleotide sequencing
The DNA sequences of fragments inserted into vac-
inia virus were determined by performing PCR with the
rimers described by Sheng et al. (1993) and sequencing
he PCR products. Southern blot analysis was performed
s described with DNA extracted from recombinant vac-
inia viruses, digested with HindIII, blotted onto a nylon
embrane (GeneScreen, DuPont NEN, Dreieich, Ger-
any), and hybridized with a 32P-labeled rotavirus cDNAene 9 probe (Ausubel et al., 1996). betection of VP7 expression by immunofluorescence,
estern blotting, and radioimmunoprecipitation (RIPA)
Polypeptides synthesized by recombinant vaccinia vi-
uses were analyzed by indirect immunofluorescence.
onolayers of CV-1 cells that had been grown to semi-
onfluency on round glass coverslips were infected with
ecombinant or control vaccinia viruses. At 9 to 16 h
ostinfection cells were fixed with 3% paraformaldehyde
n PBS for 30 min at room temperature. The coverslips
ere then treated with 1% Triton X-100 to permeabilize
he cells. After two rinses in PBS, the cells were incu-
ated for 45 min at 37°C with either hyperimmune anti-
otavirus serum bovine (Wellcome Diagnostics, Dartford,
K) diluted 1:80 in PBS containing 1% bovine serum
lbumin (PBS–BSA) or a mixture of three MAbs against
P7 (3C3, 5A10, and 4C3) (Gerna et al., 1988) diluted
:100 in PBS–BSA. After washing with PBS–BSA, appro-
riate anti-IgG sera conjugated to fluorescein (Sigma
mmunochemicals) were added for 45 min at 37°C. The
ells were then washed again and photographed with a
eitz UV photomicroscope.
For Western blotting, confluent monolayers of 143TK2
ells grown in T25 flasks were infected with recombinant
r control vaccinia viruses at a m.o.i. of 2. At 9 and 24 h
ostinfection cells were washed twice with PBS and
roteins were extracted in cell lysis buffer [0.1 M Tris z
Cl (pH 6.8), 0.2 M DTT, 4% SDS, 20% glycerol], boiled for
0 min, and centrifuged at 10,000 g for 10 min. Viral
olypeptides in the supernatants were resolved on 10%
iscontinuous polyacrylamide gels and electrotrans-
erred to nitrocellulose (Schleicher & Schuell, Dassel,
ermany) using an electroblotting apparatus (Mini
rans-blot electrophoretic transfer cell, Bio-Rad, Her-
ules, CA). Membranes were blocked by incubation in
ris-buffered saline [10 mM Tris (pH 7.5), 150 mM NaCl]
ontaining 3% BSA for 1 h and then incubated overnight
ith hyperimmune goat anti-rotavirus serum (Chemicon
nternational, Temecula, CA) diluted 1:80 in PBS–BSA.
ound antibody was detected by incubation for 2 h in a
:2000 dilution of anti-goat IgG peroxidase conjugate
Sigma Immunochemicals). After washing, final develop-
ent of the blot was performed with 3-amino-9-ethylcar-
azole (Sigma).
For immunoprecipitation experiments, confluent mono-
ayers of 143TK2 cells were infected with 20 m.o.i. of
ecombinant or control vaccinia viruses. After incubation
or 3 h at 37°C, the medium was then removed and
eplaced with methionine- and cysteine-free MEM
Sigma) containing 2.5% FBS and 20 mM HEPES. After
h of incubation, culture medium was replaced with
EM containing 50 mCi/ml of [35S]methionine:cysteine
sp act 1142 Ci/mmol, Tran35S-label, ICN Biomedicals
nc., Costa Mesa, CA). At 12 h postinfection the cells
ere washed twice with cold PBS and lysed in RIPA lysis
uffer [10 mM Tris z HCl (pH 7.8), 150 mM NaCl, 600 mM
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435CTL EPITOPES IN ROTAVIRUS VP7Cl, 5 mM EDTA, 2% Triton X-100, 1 mM PMSF, and 1
g/ml aprotinin]. Thirty microliters of radiolabeled lysate
as incubated with either 5 ml of polyclonal human
nti-rotavirus serum or 2 ml of ascitic fluid with MAb 4C3
irected against VP7. Immune complexes were precipi-
ated with protein A–Sepharose CL-4B (Sigma), washed
hree times with RIPA buffer [50 mM Tris z HCl (pH 7.4),
50 mM NaCl, 1 mM EDTA, 0.25% BSA, 0.05% Triton
-100, 0.02% N3Na], and subjected to SDS–PAGE on a
0–20% gradient gel. The gel was fixed, dried, soaked in
mplify (Amersham Pharmacia Biotech), and autoradio-
raphed as previously described (Colomina et al., 1998).
ynthetic peptides
Peptides were designed to characterize T cell
pitopes in the amino-terminal region of the SA11 VP7
olecule according to the sequence motifs described by
alk et al. (1991) for predicting CTL epitopes presented
y class I MHC molecules. These peptides were pur-
hased from Genosys Biotechnologies, Inc. (Cambridge,
K) and from Neosystem Laboratoire (Strasbourg,
rance). Their sequences, H-2 motifs, and the mouse
trains used to generate CTL responses to them are
hown in Table 1. Peptide Kb31–40 was originally de-
cribed by Franco et al. (1993) and contains two overlap-
ing Kb motifs. This peptide, covering amino acids 31–40
f VP7 from the RF strain of bovine rotavirus, was also
ested in this study, although the sequence was modified
t two residues (Y-32 to F and L-39 to F) to be adapted to
he amino acid sequence of VP7 from SA11.
Peptides were diluted in PBS containing 1% BSA and
0% DMSO to yield stock solutions of 1023 M and were
tored at 220°C.
mmunization of mice
Litters of suckling BALB/c and C57BL/6 mice (6–9 days
ld) were orally inoculated with SA11 (125 mice), Wa (158
ice), or EDIM (99 mice) rotavirus strains. The viral
oses orally given to mice were of 5 3 106 PFU for SA11
nd Wa strains and of 6 3 104 FFU for the EDIM strain.
noculated animals were housed in separate isolation
nits and were examined daily for diarrhea by gentle
alpation of the abdomen. Mock-infected animals re-
eived an equal volume of culture medium from unin-
ected MA104 cells. At 6–8 weeks of age, mice were
rimed intraperitoneally with the neonatally administered
iral strain, either homologous (105 FFU of the EDIM
train) or heterologous rotaviruses (107 PFU of either
A11 or Wa strains).
TL generation
To determine the CTL response, immunized mice were
acrificed by vertebral dislocation 5 to 7 days after the
ast virus challenge and their spleens were removed
septically. Single-cell suspensions were prepared by tareful dissection with needles and filtering the tissue
ragments through a 100-mesh sieve in a tissue grinder
Sigma). Erythrocytes were lysed in 0.85% NH4Cl in PBS
rewarmed to 37°C and lymphocytes were washed
wice in RPMI medium and finally suspended in com-
lete medium: RPMI 1640 containing 10% FBS, 20 mM
EPES, 30 mM 2-mercaptoethanol, 2.5 mM sodium pyru-
ate, 100 mg/ml streptomycin, and 100 U/ml penicillin.
timulator cells were splenocytes obtained from nonim-
une syngeneic mice, incubated with 1 m.o.i. of rotavirus
or 1 h, and treated afterward for 20 min with 25 mg/ml
itomycin C (Boehringer Mannheim, Mannheim, Ger-
any). These cells were washed three times and mixed
ith the effector cell population in a 1:2 ratio. Cell mix-
ures were adjusted to 5 3 106 cells/ml in RPMI complete
edium, distributed in 24-well plates, and incubated for
days at 37°C to allow stimulation and expansion of
irus-specific CTL precursor cells (CTLp). For stimulation
ith peptides, splenocytes were incubated with each
eptide at 1024 M for 5 days at 37°C.
ytotoxicity assay
A standard 51Cr release assay (Whitton et al., 1988a;
ffit and Dudzik, 1988; Franco et al., 1993) was used to
easure CTL activity. For use as target cells, MC57, Balb
l.7, or P815 cells were infected with 2–5 m.o.i. of vac-
inia virus recombinants or with 100–130 m.o.i. of rotavi-
us SA11. After a 5-h incubation at 37°C, the cells were
rypsinized, washed, counted, centrifuged, and labeled
or 1 h at 37°C with 50–100 mCi of 51Cr (Amersham
harmacia Biotech). Cells were then washed three times
nd distributed in 96-well plates at 10,000 cells/well. For
TL assays performed with peptides, target cells were
abeled with 51Cr and distributed in 96-well plates as
bove and then incubated for 2 h at 37°C with peptides
t 1026 M. Serial dilutions of peptides from 1025 to 10212
were used to sensitize target cells when the screening
xperiment showed significant lysis values.
Effector cells were added at the appropriate concen-
rations to obtain various effector:target (E:T) cell ratios
12.5:1, 25:1, and 50:1) in a total volume of 200 ml. In CTL
ssays performed with peptides, the E:T cell ratio used
as 50:1. Spontaneous and total releases of 51Cr were
alculated by incubating target cells in each experiment
ith medium only and with 10% Triton X-100, respectively.
fter a 5-h incubation at 37°C the plates were centri-
uged at 500 g for 5 min and 100 ml of supernatant was
emoved from each well and counted in a gamma
ounter (SpectraGamma, Packard Instruments Co.,
eriden, CT). The percentage of specific lysis was cal-
ulated as 100 3 [(cpm released by CTL 2 cpm of
pontaneous release)/(cpm of total release 2 cpm of
pontaneous release)]. A response was considered pos-
tive when it was at least double the lysis value of control
arget cells (mock-infected and/or VV-sc11-infected
c
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436 BUESA ET AL.ells). The results were obtained from two or three ex-
eriments and each experiment was performed in tripli-
ate. Results are expressed as mean values plus and
inus the standard error of the mean (SEM).
tatistical analysis
Analysis of variance was carried out on the percent-
ge lysis values to test for significant differences be-
ween different experimental groups. The two-tailed Stu-
ent t test was used to compare the differences between
ndividual group means. Significance, when applied in a
tatistical comparison, implies a P value of ,0.001.
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